Ruxolitinib Cream 1% Led to a Rapid, Significant Reduction in Atopic Dermatitis-Related Pruritus.

Published Date: 04 May 2023

Ruxolitinib 10.5 percent demonstrated strong results for quickly reducing itching in eczema patients, and this improvement persisted for 28 days, according to new phase 2 data from the SCRATCH-AD trial.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Vaccine shows promise for pancreatic cancer, study finds

2.

After a plane crash, a surgeon dies; Austin is released from the hospital; and an animal pandemic spreads.

3.

FAPI PET/CT enhances the staging of recently discovered breast cancer, according to comparative analysis.

4.

"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.

5.

Tumor characteristics found to differ for melanomas in children, teens and young adults


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot